According to our results, the frequency of these cells would be especially low in those MS patients carrying the rs10892307 variant risk allele (C), which prompts us to speculate that the risk allele is associated with a lower limitation of the germinal centers reaction by Tfr cells and, therefore, with a greater probability that antibodies against own antigens are generated. The gene discussed is TFRC; the disease is myeloid sarcoma.